Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Tandem Diabetes Care | TNDM | Aug 30, 2024 | 43.50 | -1.58 |
Tanger | SKT | Aug 30, 2024 | 30.44 | +0.86 |
Tango Therapeutics | TNGX | Aug 30, 2024 | 11.83 | +6.38 |
Tantech | TANH | Aug 30, 2024 | 0.14 | -2.78 |
Taoping | TAOP | Aug 30, 2024 | 0.56 | +1.31 |
Tapestry | TPR | Aug 30, 2024 | 40.97 | +1.11 |
Targa Resources | TRGP | Aug 30, 2024 | 146.90 | +0.42 |
Target | TGT | Aug 30, 2024 | 153.62 | +0.13 |
Target Global Acquisition I A | TGAA | Aug 30, 2024 | 11.26 | 0.00 |
Target Global Acquisition I Unit | TGAAU | Aug 30, 2024 | 11.29 | 0.00 |
Target Hospitality | TH | Aug 30, 2024 | 9.69 | -0.72 |
Tarsus Pharmaceuticals | TARS | Aug 30, 2024 | 27.11 | -1.78 |
Taseko Mines | TGB | Aug 30, 2024 | 2.26 | +2.73 |
TaskUs A | TASK | Aug 30, 2024 | 13.30 | -1.48 |
TAT Technologies | TATT | Aug 30, 2024 | 17.46 | -2.84 |
Taylor Devices | TAYD | Aug 30, 2024 | 57.22 | +2.18 |
Taylor Morrison Home | TMHC | Aug 30, 2024 | 67.33 | +1.11 |
Taysha Gene Therapies | TSHA | Aug 30, 2024 | 2.24 | +4.19 |
TC Bancshares | TCBC | Aug 30, 2024 | 13.10 | 0.00 |
TC Biopharm ADR | TCBP | Aug 30, 2024 | 5.57 | +4.31 |
TC Energy | TRP | Aug 30, 2024 | 46.34 | +1.29 |
TCTM Kids IT Education ADR | TCTM | Aug 30, 2024 | 1.14 | -2.56 |
TCW Strategic | TSI | Aug 30, 2024 | 5.12 | -0.39 |
TD Synnex | SNX | Aug 30, 2024 | 121.42 | +0.61 |
TDH Holdings | PETZ | Aug 30, 2024 | 1.23 | +2.50 |
TE Connectivity | TEL | Aug 30, 2024 | 153.60 | +1.39 |
Team | TISI | Aug 30, 2024 | 13.67 | -2.36 |
TechnipFMC Plc | FTI | Aug 30, 2024 | 26.84 | -0.22 |
Technology & Telecommunication Acquisition A | TETE | Aug 30, 2024 | 12.08 | +0.50 |
Technology Alphadex First Trust | FXL | Aug 30, 2024 | 136.16 | +0.90 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.